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urinary L-FABP compared with other urinary biomarkers for the early detection of AKI among patients who have undergone cardiac surgery.
Methods

Patient Selection
Adult patients undergoing cardiac surgery in the Department of Cardiovascular Surgery, St Marianna University School of Medicine were eligible for enrollment. A total of 85 patients who were admitted to the coronary care unit (CCU) after cardiac surgery were prospectively studied from August 2009 to October 2010. Patients who depended on chronic dialysis support, patients undergoing emergency operation (operation performed within 24 h after admission) and patients who died within the first 24 h after surgery were excluded from this study. Patients were divided into the AKI and non-AKI groups according to whether they developed AKI within 48 h after surgery. Postoperative AKI was defined according to AKIN criteria, which is an absolute increase in SCr of ≥26.4 μmol/L (0.3 mg/dl) from baseline or a relative increase in SCr of >1.5-fold from baseline within the first 48 h after cardiac surgery. 9 The present study was carried out according to the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients, and the institutional review board approved the study protocol.
Urine and Serum Sample Collection and Storage
Ten milliliters of urine was obtained through the urinary catheter at the following time points from each patient: before the operation, immediately after the operation, and 3, 6, 18, 24, and 48 h postoperatively. Serum samples were obtained at the same time points as urine collection and the SCr levels were determined. The urine samples were centrifuged at 1,000 g at 4ºC for 5 min and the supernatants were stored at -80ºC until analysis.
Enzyme-Linked Immunosorbent Assay for Measurement of Urinary L-FABP and Neutrophil Gelatinase-Associated Lipocalin
The level of urinary L-FABP was measured on enzyme-linked immunosorbent assay (ELISA) using the Human L-FABP ELISA kit (CMIC, Tokyo, Japan). 17 The level of urinary neutrophil gelatinase-associated lipocalin (NGAL) was measured using the NGAL Rapid ELISA Kit (BioPorto, Gentofte, Denmark). 18 Biomarker Measurements in Blood and Urine Serum creatinine, urinary creatinine, urinary albumin, and urinary N-acetyl-β-D-glucosaminidase (NAG) levels were measured. The levels of urinary biomarkers are expressed as a ratio of the level of urinary creatinine.
Statistical Analysis
Results are expressed as median (range or 25-75% interquartile range) or mean ± SEM. To compare 2 groups, the MannWhitney U-test was used for unpaired data. Categorical variables were compared using chi-square test. Differences among the same group were analyzed using 1-way analysis of variance 
Results
Patient Characteristics
This study included 85 patients who were admitted to the CCU after cardiac surgery. Forty-eight patients (56%) developed AKI within the first 48 h after cardiac surgery and were placed in the AKI group, while the remaining 37 patients did not and were placed in the non-AKI group. The characteristics of the AKI and non-AKI groups are listed in Three patients in the AKI group died in the hospital. With respect to age, gender, comorbid diseases and body mass index (BMI), no differences were noted between the AKI and non-AKI groups ( Table 1) . As to concomitant medications such as renin-angiotensin-aldosterone system (RAAS) blockade treatment and diuretics before operation, significantly higher percentages of patients in the AKI group were taking these medications compared with the non-AKI group (P=0.044 and P=0.029, respectively; Table 1 ). The operation time was significantly longer in the AKI group than in the non-AKI group (P=0.043). The length of CCU stay and length of hospital stay were significantly longer in the AKI group than in 
Urinary Parameters and Renal Function
Changes in various parameters in the AKI and non-AKI groups are shown in Table 2 and Figure. Although there was no difference in the SCr level between the 2 groups prior to operation, the SCr level was significantly higher in the AKI group than in the non-AKI group up to and including 48 h after surgery. The urinary L-FABP level in the AKI group was significantly higher than that in the non-AKI group before operation and up to and including 48 h after the surgery. In the AKI group, the urinary L-FABP level was significantly higher immediately after operation and at 3 h after the surgery compared with the respective level before operation. The urinary NGAL level was significantly higher in the AKI group than in the non-AKI group before operation and up to and including 48 h after the surgery except at immediately after the operation. In addition, in the AKI group, there was no difference in urinary NGAL level between the preoperative level and the immediately postoperative level. The urinary albumin level was significantly higher in the AKI group than in the non-AKI group at all time points. In the AKI group, there were no differences in urinary albumin level between the preoperative level and the level at each time point after the surgery. The urinary NAG level was significantly higher in the AKI group than in the non-AKI group at 3 h after the operation. In the AKI group, there were no differences in urinary NAG between the preoperative level and the level at each time point after the surgery.
ROC Analysis of Urinary Biomarkers for Predicting Onset of AKI
The biomarker with the largest AUC for predicting the onset of AKI was urinary L-FABP at all time points (Table 3) . Before operation, immediately after the operation, and 3, 6, 18, 24, and 48 h after the surgery, the AUCs for predicting the onset of AKI in urinary L-FABP were 0.80, 0.86, 0.85, 0.83, 0.76, 0.78, and 0.75, respectively -the largest AUC for predicting the onset of AKI being at immediately after the operation. Within the first 6 h after cardiac surgery, namely the early time points after the operation, the AUCs of urinary L-FABP were >0.80 at each time point. These results suggest that urinary L-FABP is a good early predictor of the onset of AKI after cardiac surgery.
Logistic Regression Analysis for Prediction of Onset of AKI
We performed multiple logistic regression analysis using the Table 2 . Table 4 ). Moreover, at the preoperation time point, multiple logistic regression analysis incorporating estimated GFR (eGFR) and the variables listed in the previous section showed that urinary L-FABP was the only predictor that was significantly associated with the onset of AKI (P=0.03, OR, 3.739; 95%CI: 1.133-12.335; Table 4 ).
Urinary L-FABP as a Biomarker for Early Detection of AKI
Because urinary L-FABP was the only predictor that was significantly associated with the onset of AKI (Table 4) , we determined the cut-off value of urinary L-FABP at each time point ( Table 5) .
Discussion
In this prospective study of 85 adult patients who underwent cardiac surgery, we report 4 notable findings. First, although there was no difference in the preoperative SCr level between the AKI group and non-AKI group, the preoperative urinary L-FABP, urinary NGAL, and urinary albumin levels were significantly higher in the AKI group than in the non-AKI group. Second, the urinary L-FABP level was significantly higher in the AKI group than in the non-AKI group at every time point, while other parameters did not show such a tendency. Moreover, in the AKI group, the urinary L-FABP level was significantly higher up to and including 3 h after the operation compared with the preoperative level. Third, the biomarker with the largest AUC at every time point for predicting the onset of AKI was urinary L-FABP. Especially, within the first 6 h after cardiac surgery, the AUC of urinary L-FABP was >0.80 at each time point. Fourth, on multiple logistic regression using parameters measured at each time point, the urinary L-FABP level before operation and within the first 6 h after cardiac surgery was significantly associated with the onset of AKI. These results suggested that the presence of tubular damage and the deterioration of tubular structure are risk factors for the onset of AKI, and that urinary L-FABP is a useful biomarker for the early detection of AKI and is a good early predictor of the onset of AKI.
L-FABP was recently designated as a new clinical biomarker of tubular damage by the Ministry of Health, Labour and Welfare in Japan. The dynamics of renal L-FABP in kidney disease were determined in many experimental studies of chronic kidney disease or AKI. Renal L-FABP gene expression is upregulated and urinary excretion of L-FABP is increased by various stresses, for example urinary protein overload, 19 tubular ischemia, 20 tubular stretch, 21 hyperglycemia, 22 ischemia/ reperfusion, 23 and toxins, 14 which cause tubulointerstitial damage. Tubular stress that causes AKI may upregulate renal L-FABP expression and then accelerate urinary excretion of L-FABP from the proximal tubules. Urinary L-FABP level was significantly associated with the degree of tubulointerstitial damage and increased in accordance with the progression of kidney disease. 14 Therefore, we considered that the urinary L-FABP level may increase before the occurrence of tubular structural damage, may be a useful biomarker for early detection of AKI and may be a real-time indicator of tubulointerstitial damage.
Cardiac surgery changes renal hemodynamics and decreases renal blood flow. 24 The medullary region in the kidney exists on a hypoxic precipice as a result of low blood flow and countercurrent exchange of oxygen, although paradoxically housing nephron segments with very high energy requirements (eg, the S3 segment of the proximal tubule). The ischemic state after cardiac surgery worsens the relative hypoxia, leading to prolonged cellular injury and cell death in these predisposed tubule segments. 25 In the pathogenesis of AKI after cardiac surgery, tubulointerstitial damage provoked by ischemia/ reperfusion is an important factor that leads to the onset of AKI. 25,26 Because L-FABP is expressed in cells lining the straight portion of the proximal tubules (S3 segment) in addition to S1 and S2 segments of the proximal tubules within the kidney, renal L-FABP gene expression and urinary excretion of L-FABP from the proximal tubules may be susceptible to increase in accordance with the ischemic state after cardiac surgery. The urinary L-FABP level was significantly higher in the AKI group than in the non-AKI group at every time point, while other parameters did not show such a tendency in this study. The presence of tubulointerstitial damage before cardiac surgery and the strong induction of tubulointerstitial damage after the surgery were associated with the onset of AKI. The urinary L-FABP level precisely reflects such pathophysiology of AKI.
When is the most suitable time for measurement of urinary L-FABP for early detection of AKI in adult patients who undergo cardiac surgery? The highest urinary L-FABP level among the measured time points in the AKI group, the largest AUC of urinary L-FABP for predicting the onset of AKI and the lowest P-value of urinary L-FABP that was independently associated with the onset of AKI, were seen in the urine sample obtained immediately after operation. Measurement of urinary L-FABP immediately after cardiac surgery may help physi- Tables 1,3 . Urinary Parameters of AKI After Cardiac Surgery cians predict the onset of AKI, guide appropriate care and prevent the progression to AKI. Moreover, the cut-off value of urinary L-FABP in the urine sample obtained immediately after the operation for predicting the onset of AKI (ie, 54.59 μg/gCr), was considered to be adequate because this was similar to the cut-off for predicting the onset of AKI in patients admitted to the intensive care unit in our previous study. 27 Therefore, we suggest that the optimal timing of measurement of urinary L-FABP for predicting the development of AKI is immediately after operation. In contrast, as a screening tool for patients at high risk for postoperative AKI, preoperative measurement of urinary L-FABP was suboptimal. Although the AUC of preoperative urinary L-FABP for predicting the onset of AKI was lower than that of the postoperative urinary L-FABP within the first 6 h, if patients at high risk for developing AKI are screened using preoperative urinary L-FABP, we might be able to take steps to avoid risk factors for postoperative AKI, such as instituting RAAS blockade treatment, diuretics, and hypotension during the operation ( Table 1) , and we might be able to manage high-risk patients such as patients with metabolic syndrome, 28 diabetes mellitus, 28,29 and anemia 29 more carefully. Urinary NGAL was reported to be another biomarker for early detection of AKI after cardiac surgery. In a study of children undergoing cardiac surgery, 30 the urinary concentration of NGAL 2 h after surgery was nearly 100% accurate for correctly identifying patients who developed AKI 14-72 h after surgery. In contrast, subsequent studies have not yielded results as robust as those produced in the initial study. In a cohort of adults undergoing cardiac surgery, the best AUC for urinary NGAL concentration was only 0.80 at the time point of 18 h after surgery. Other time points, both immediately after surgery (2 and 12 h) and 24 h after surgery, did not possess diagnostic accuracy as high. 31 In addition, Koyner et al reported that urinary NGAL had AUC-ROCs of between 0.61 and 0.70 at various time points after cardiac surgery in adult patients. 32 Similarly, less robust results were produced in the present study, in which the best AUC for urinary NGAL was 0.77 at the time point of 24 h after surgery.
What is the difference between urinary L-FABP and urinary NGAL for early detection of AKI in adult patients who undergo cardiac surgery? The difference in the pattern of increase of urinary NGAL and urinary L-FABP after cardiac surgery results from differences in the mechanism of urinary secretion. In the AKI setting, various stresses, especially oxidative stress, the presence of tissue hypoxia and tubule ischemia, upregulate renal L-FABP expression, and there is increased secretion (or shedding) of L-FABP from damaged proximal tubular cells into the luminal space of proximal tubules. 33, 34 In contrast, under normal conditions, NGAL is filtered by glomeruli and reabsorbed by proximal tubules, leaving only 0.1-0.2% in the urine. 35 In the AKI setting, first, various stresses increase serum NGAL in the circulation, which induces activation of neutrophils, and then, an increased amount of NGAL is filtered from the glomerular filtrate. Some NGAL molecules are reabsorbed by the damaged proximal tubules while others are excreted. Therefore, increased urinary NGAL is mainly due to impaired renal reabsorption, 36 and it takes a relatively longer period of time for the urinary NGAL level to increase compared with the urinary L-FABP level.
Another difference between urinary L-FABP and urinary NGAL for early detection of AKI in adult patients who undergo cardiac surgery relates to whether they are affected by preoperative comorbidities or not. Urinary NGAL is readily influenced by preoperative comorbidities such as diabetes, hypertension, hyperlipidemia and cardiovascular disease. Wagener et al reported that because of increased rates of preoperative comorbidities in adults, the ability of urinary NGAL to predict AKI after cardiac surgery in adults was inferior to that in children. 37 In the present study and in the Wagener et al study, 37 many patients had an increase in urinary NGAL level after cardiac surgery, and only the degree of the change differed in patients with or without AKI compared with the pediatric population who do not have preoperative comorbidities. In contrast, urinary L-FABP is a well-established biomarker both in children 15 and in adults. 27 In the present study we did not measure serum L-FABP in either the AKI group or in the non-AKI group. Previous studies in patients with chronic kidney disease, acute renal failure and sepsis have shown that serum L-FABP level does not influence the urinary level. 38, 39 Thus, we did not measure serum L-FABP level in the present study.
Some findings in the present study conflicted with previous studies. Wijeysundera et al proposed that preoperative eGFR <60 ml/min was an independent predictor that was significantly associated with the onset of AKI, and lower preoperative eGFR was a stronger predictive factor for the onset of AKI. 40 In the present study, the preoperative eGFR level, which was estimated using the equation proposed by the Japanese Society of Nephrology {eGFR (ml · min −1 · 1.73 m −2 )=194 × Cr −1.094 × Age −0.287 × 0.739 (if female)}, 41 was significantly lower in the AKI group (57.4±2.6 ml · min −1 · 1.73 m −2 ) than in the non-AKI group (71.8±3.9 ml · min −1 · 1.73 m −2 ; P=0.008). Preoperative eGFR, however, was not an independent predictor on multiple logistic regression analysis. Furthermore, although the operation time was longer in the AKI group than in the non-AKI group, the operation time was not a risk factor for the onset of AKI. Because patients who were scheduled to undergo various surgical procedures were recruited in the present study, we speculate that the operation time directly reflected the ischemic period during which renal blood flow was reduced. In order to clarify these points, further research in a large-scale multicenter trial is needed.
Conclusions
In adult patients, the presence of tubular damage and the deterioration of tubular structure were risk factors for the onset of AKI, and urinary L-FABP was a useful biomarker for early detection of AKI and was a good early predictor for the onset of AKI. Further investigation is required to establish the optimal timing of urinary L-FABP measurement and the optimal cut-off points for clinical use of urinary L-FABP in the cardiac surgical department.
